Dr. Ng has over 30 years of experience in the chemical, pharmaceutical and biopharmaceutical industry. He started as a research investigator at Occidental Chemicals and moved to work in the pharmaceutical and biotech industry at Searle/Monsanto/Pharmacia where he led multiple scientific teams to develop key manufacturing processes for many commercial products in multiple therapeutic areas. Before joining CoMentis, Dr. Ng spent many years in biopharmaceutical companies in numerous scientific leadership positions at Amgen, Anadys Pharmaceuticals and Genentech/Roche in the development and manufacturing departments.
Dr. Ng joined CoMentis in August 2008 as the Director of CMC where he was responsible for all CMC functions.
He was promoted to Vice President in February 2012. Dr. Ng is responsible for the research and development operations. He also serves on the Joint Development Committee and Joint Steering Committee for the CoMentis-Astellas collaboration on the BACE inhibitor program.
Dr. Ng received his Bachelor of Science degree in chemistry from Brandeis University and his Ph.D. from the University of Illinois at Urbana-Champagne.